Abstract
The implementation of electronic medical records (EMR) systems was mandated by the U.S. federal government in large part due to research indicating that difficulty accessing clinical data was one of the most common causes of preventable deaths. Several assumptions were implicit in this mandate, including the assumption that the implementation of EMR would indeed improve clinicians’ access to clinical data, that implementation of EMR would pose little to no risk to patients, and that the clinical benefit of improved access to clinical data would outweigh any risks that might arise. As detailed in this review, both formal research and extensive experiential observation have called all three assumptions into question. Specifically, as detailed below, there is clear evidence that EMR systems are associated with multiple specific risks to patients, whereas few, if any, scientifically rigorous outcomes-based studies have demonstrated that the potential benefits of EMR outweigh the known risks. In addition, there is currently little to no scientifically rigorous evidence that EMR systems constitute a cost-effective methodology for improving patient outcomes.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
•• Kohn LT, Corrigan JM, Donaldson MS. To Err is human: Building a safer healthcare system. Washington, DC: National Academy Press; 1999. p. 1–15. A substantial fraction of preventable inpatient deaths are attributable to processes and systems that predispose to medical errors.
Blumenthal D. Wiring the health system – origins and provisions of a new federal program. N Engl J Med. 2011;365:2323–9.
Burstin H. The journey to electronic performance measurement. Ann Intern Med. 2013;158:131–2.
Cimino JJ. Improving the electronic health record – are clinicians getting what they wished for? JAMA. 2013;309:991–2.
Crosson JC, Bazemore AW, Phillips RL. EHR implementation without meaningful use can lead to worse outcomes. Am Fam Physician. 2011;84:1220.
DesRoches CM, Audet A-M, Painter M, Donelan K. Meeting meaningful use criteria and managing patient populations. Ann Intern Med. 2013;158:791–9.
Fackler JC. Stop the noise and get to the point. Crit Care Med. 2013;41:656–7.
Flodgren G, Eccles MP, Shepperd S, et al. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev. 2011;CD009255:1–94.
Han YY, Carcillo JA, Venkataraman ST, et al. Unexpected increase in mortality after implementation of a commercially sold computerized physician order entry system. Pediatrics. 2005;116:1506–12.
Jones SS, Heaton PS, Rudin RS, Schneider EC. Unraveling the IT productivity paradox – lessons for health care. N Engl J Med. 2012;366:2243–5.
•• Kern LM, Malhotra S, Barron Y, et al. Accuracy of electronically reported “meaningful use” clinical quality measures. Ann Intern Med. 2013;158:77–83. EMR systems generate quality metrics of highly questionable accuracy, which undermines both the validity and efficacy of EMR-based pay-for-performance programs.
Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medical errors. JAMA. 2005;293:1197–203.
Koppel R. Demanding utility from health information technology. Ann Intern Med. 2013;158:845–6.
Lin C-T, McKenzie M, Pell J, Caplan L. Health care provider satisfaction with a new electronic progress note format: SOAP vs APSO format [letter]. JAMA Intern Med. 2013;173:160–2.
Love JS, Simon SR, Jenter CA, et al. Are physicians’ perceptions of healthcare quality and practice satisfaction affected by errors associated with electronic health record use? J Am Med Inform Assoc. 2012;19:610–4.
Mandl KD, Kohane IS. Escaping the EHR trap – the future of health IT. N Engl J Med. 2012;366:2240–2.
Mangalmurti SS, Murtagh L, Mello MM. Medical malpractice liability in the age of electronic health records. N Engl J Med. 2010;363:2060–7.
Parsons A, McCullough C, Wang J, Shih S. Validity of electronic health record-derived quality measurement for performance monitoring. J Am Med Inform Assoc. 2012;19:604–9.
Rosof B. The importance of accurate data in quality-of-care measurement. Ann Intern Med. 2012;157:379–80.
Thornton JD, Schold JD, Venkateshaiah L, Lander B. Prevalence of copied information by attendings and residents in critical care progress notes. Crit Care Med. 2013;41:382–8.
Villier JA. Dispensing of electronically discontinued medications [letter]. Ann Intern Med. 2013;158:571.
Yasnoff WA, Sweeney L, Shortliffe EH. Putting health IT on the path to success. JAMA. 2013;309:989–90.
Needleman J, Buerhaus P, Pankratz VS, et al. Nurse staffing and inpatient hospital mortality. N Engl J Med. 2011;364:1037–45.
Baker DW, Qaseem A. Evidence-based performance measures: preventing unintended consequences of quality measurement. Ann Intern Med 2011;155:638–40.
Bray BD. Hospital pay for performance in England [letter]. N Engl J Med. 2013;368:968.
Farmer SA, Black B, Bonow RO. Tension between quality measurement, public quality reporting, and pay for performance. JAMA. 2013;309:349–50.
•• Fonarow GC, Pan W, Saver JL, et al. Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA. 2012;308:257–64.
Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relationship between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:326–31.
Baker KS, Davies SM, Majhail NS, et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15:1543–54.
Berkman ND, Sheridan SL, Donahue KE, et al. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155:97–107.
Greiver M, Keshavjee K, Martin K, Aliarzadeh B. Who are your patients with diabetes? Can Fam Physician. 2012;58:804.
Peterson PN, Shetterly SM, Clarke CL, et al. Health literacy and outcomes among patients with heart failure. JAMA. 2011;305:1695–701.
Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, et al. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000;89:2202–13.
Selby GB, Ali LI, Carter TH, et al. The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML [letter]. Biol Blood Marrow Transplant. 2001;7:576–7.
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–36.
Werner RM. Will using medicare data to rate doctors benefit patients? Ann Intern Med. 2012;156:532–3.
Glickman SW, Ou F-S, DeLong ER, et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA. 2007;297:2373–80.
Houle SKD, McAlister FA, Jackevicius CA, et al. Does performance-based remuneration for individual health care practitioners affect patient care? Ann Intern Med. 2012;157:889–99.
Jha AK, Joynt KE, Orav EJ, Epstein AM. The long-term effect of premier pay for performance on patient outcomes. N Engl J Med 2012;366:1606–15.
Jha AK. Time to get serious about pay for performance. JAMA. 2013;309:347–8.
Landrigan CP, Parry GJ, Bones CB, et al. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med. 2010;363:2124–34.
Lee GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med. 2012;367:1428–37.
Tu JV, Donovan LR, Lee DS, et al. Effectiveness of public report cards for improving the quality of cardiac care. JAMA. 2009;302:2330–7.
Burstein HJ. A “shot heard ‘round the world” on cancer drug costs? J Natl Compr Cancer Netw. 2012;10:1315–6.
Goss E, Lopez AM, Brown CL, et al. American Society of Clinical Oncology policy statement: disparities in cancer care. J Clin Oncol. 2009;27:2881–5.
Kantarjian H. The price of drugs for chronic myelogenous leukemia (CML) is a reflection of unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood. 2013;121:4439–42.
Kumar P, Moy B. Cancer health disparities and the cost of cancer care: payment model issues. J Natl Compr Cancer Netw. 2013;11:633–6.
Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol. 2007;25:180–6.
Snyder L. American College of Physicians Ethics Manual. Ann Intern Med. 2012;156:73–104.
Compliance with Ethics Guidelines
Conflict of Interest
Thomas R. Klumpp declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klumpp, T.R. Electronic Medical Records and Quality of Cancer Care. Curr Oncol Rep 15, 588–594 (2013). https://doi.org/10.1007/s11912-013-0347-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-013-0347-z